Browsing by Author "Ozbay, Gulsen"
Now showing items 1-9 of 9
-
Adult Langerhans cell histiocytosis and sclerosing cholangitis: a case report and review of the literature
Ozbay, Gulsen; HATEMİ, Ali İbrahim; Baysal, Birol; Senturk, HAKAN; Behzatoglu, Kemal; Bozkurt, Erol Rustu (2010-09-01)Sclerosing cholangitis is a rare complication of Langerhans cell histiocytosis in children which can result in liver failure. This combination is even rarer in adults. -
Hepatic apoptotic markers are not predictors for the virological response to interferon-based therapy in chronic hepatitis C patients
Tozun, Nurdan; YENICE, Necati; ÇELİKEL, ÇİĞDEM; Midilli, Kenan; FINCANCI, Muzaffer; Gucin, ZÜHAL; Mert, Ali; Tabak, Fehmi; Osme, Abdullah; Senturk, Hakan; Ozaras, Resat; Tahan, Veysel; Ozbay, Gulsen; Ozturk, Recep (2015-09-01)IntroductionChronic hepatitis C virus (HCV) infection is a major health problem worldwide. The majority of cases involving HCV infection develop into chronic hepatitis because of a failure to develop an effective immune ... -
Insulin Resistance is Associated With Increased Apoptosis and Oxidative Stress in Non-Alcoholic Fatty Liver Disease
Tuncer, Murat; Canbakan, Billur; Ozbay, Gulsen; HATEMİ, Ali İbrahim; Senturk, HAKAN; Yurdakul, Ibrahim; SONSUZ, Abdullah; Erzin, Yusuf (2012-05-01) -
Is Alanine Aminotransferase a Surrogate Marker of Severe Hepatocyte Apoptosis in Patients With Non-Alcoholic Fatty Liver Disease
Canbakan, Billur; Toptas, Tayfur; HATEMİ, Ali İbrahim; Senturk, HAKAN; Canbakan, Mustafa; Ozbay, Gulsen; Olgac, Vakur; Balci, Huriye; Tabak, Omur (2010-05-01) -
Long-Term Effect of Interferon Therapy in Patients with HBeAg Positive Chronic Hepatitis B Infection
Baysal, Birol; Tabak, Fehmi; Ozaras, Resat; Zerdali, Hasan; Tahan, Veysel; Senturk, HAKAN; Ozbay, Gulsen; Tabak, Omur; Canbakan, Billur; Mert, Ali (2011-01-01)Introduction Several studies have reported that interferon therapy increases elimination rate of HBeAg and anti-HBe seroconversion in chronic hepatitis B (CHB) patients. We aimed to evaluate long-term results of interferon-alpha ... -
Role of Oxidative Stress and Insulin Resistance in the Disease Severity of Non-Alcoholic Fatty Liver Disease
Senturk, HAKAN; Koroglu, Emine; HATEMİ, Ali İbrahim; Tuncer, Murat; Canbakan, Billur; Ozbay, Gulsen; SONSUZ, Abdullah (2013-05-01) -
The Efficacy of Interferon Treatment in HBeAg Positive Chronic Hepatitis B is Very Low in an Area With Exclusively D Genotype
Senturk, HAKAN; Ozbay, Gulsen; Ozaras, Resat; Baysal, Birol; Tabak, Omur; HATEMİ, Ali İbrahim; Canbakan, Billur; Mert, Ali; Tabak, Fehmi; Zerdali, Hasan (2010-05-01) -
Validation of Biochemical Markers for the Prediction of Liver Fibrosis and Activity in Hemodialysis Patients With Chronic Hepatitis C
Canbakan, Mustafa; Tabak, Omur; HATEMİ, Ali İbrahim; Senturk, HAKAN; Canbakan, Billur; Toptas, Tayfur; Ozbay, Gulsen; Balci, Huriye; Tabak, Fehmi; Ozaras, Resat (2010-05-01) -
Validation of Biochemical Markers for the Prediction of Liver Fibrosis and Necroinflammatory Activity in Hemodialysis Patients with Chronic Hepatitis C
Senturk, HAKAN; Ozaras, Resat; Tabak, Omur; TOPTAŞ, TAYFUR; Canbakan, Billur; Canbakan, Mustafa; Ozbay, Gulsen; Sut, Necdet; Balci, Huriye; Tabak, Fehmi (2011-01-01)Background: Liver biopsy is an imperfect gold standard for assessing the disease severity in hemodialysis patients with chronic hepatitis C. Our purpose was to compare the accuracy of the FibroTest (FT) and ActiTest (AT) ...
